History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia

European Journal of Haematology

Volumn 89, Issue 4, 2012, Pages 336-339

  Fransen van de Putte, Dietje E ^a   Fischer, Kathelijn ^b   Makris, Michael ^c   Tait, R Campbell ^d   Chowdary, Pratima ^e   Collins, Peter W ^f   Meijer, Karina ^g   Roosendaal, Goris ^a   Schutgens, Roger E G ^a   Mauser Bunschoten, Eveline P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angina; Cardiovascular disease; Haemophilia; Myocardial infarction; Stroke

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CAUCASIAN; COHORT ANALYSIS; DISEASE SEVERITY; HEART INFARCTION; HEMOPHILIA; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; GREAT BRITAIN; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; NETHERLANDS;

EID: 84866367842     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01835.x     Document Type: Article

References (8)

1. Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-6.
2. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007;110:815-25.
3. Koumbarelis E, Rosendaal FR, Gialeraki A, Karafoulidou A, Noteboom WM, Loizou C, Panayotopoulou C, Markakis C, Mandalaki T. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994;72:808-13.
4. Fransen van de Putte DE, Fischer K, Pulles AE, Roosendaal G, Biesma DH, Schutgens REG, Mauser-Bunschoten EP. Non-fatal cardiovascular disease, malignancies and other co-morbidity in adult haemophilia patients. Thromb Res 2012;130:157-62.
5. Fabri DR, de Paula EV, Costa DSP, Annichino-Bizzacchi JM, Arruda VR. Novel insights into the development of atherosclerosis in hemophilia A mouse models. J Thromb Haemost 2011;9:1556-61.
6. Sartori MT, Bilora F, Zanon E, Varvarikis C, Saggiorato G, Campagnolo E, Pagnan A, Cella G. Endothelial dysfunction in haemophilia patients. Haemophilia 2008;14:1055-62.
7. Sramek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001;104:762-7.
8. Tuinenburg A, Rutten A, Kavousi M, et al. Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:799-804.